Patents
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
05/2011
05/05/2011US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors
05/05/2011US20110105432 Aminocarboxylic acid derivative and medicinal use thereof
05/04/2011EP2315756A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
05/04/2011CN101638394B 6-nitro anti-caking agent and use method thereof
04/2011
04/27/2011EP2313380A1 Oxadiazole derivatives for treating diabetes
04/27/2011EP1841426B1 Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of alzheimer's disease
04/26/2011CA2477657C Cathepsin cysteine protease inhibitors
04/21/2011WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses
04/21/2011US20110092554 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
04/20/2011EP2310378A2 Oxadiazole-2-oxides as antischistosomal agents
04/19/2011CA2384417C Novel dicarboxylic acid derivatives with pharmaceutical properties
04/14/2011WO2011044307A1 Phenyloxadiazole derivatives as pgds inhibitors
04/14/2011WO2011043480A1 Homocysteine synthase inhibitor
04/14/2011WO2011043479A1 Therapeutic agent for cerebral infarction
04/14/2011US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
04/14/2011CA2776242A1 Phenyloxadiazole derivatives as pgds inhibitors
04/13/2011EP2307381A2 New drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
04/13/2011EP2307023A1 Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase
04/13/2011EP2307013A1 Pain-relieving compositions of furoxan no donors and uses thereof
04/13/2011CN101519385B Small molecule compound being capable of promoting proliferation of stem cells and function thereof
04/12/2011US7923462 Catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
04/12/2011CA2471099C .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors
04/12/2011CA2387107C Derivatives of dicarboxylic acid having pharmaceutical properties
04/06/2011EP2305640A2 Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases
04/06/2011EP2305636A1 Selective androgen receptor modulators and methods of use thereof
04/06/2011EP1836149B1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
04/06/2011CN102007107A Novel aminomethyl benzene derivatives
04/06/2011CN102007103A Substituted sulfonic acid amide compounds
04/06/2011CN102002014A Preparation method of substituted 1,3,4-diazole-2-(3H)-ketone
04/06/2011CN101068796B Compounds, compositions and thin films
04/05/2011US7919496 5-[4-(2-Trifluoromethylbenzoyl)piperazin-1-yl]-[1,3,4]thiadiazole-2-carboxylic acid ethyl ester; metabolic disorders type II diabetes, impaired glucose tolerance, insulin resistance, obesity, fatty liver, non-alcoholic steatohepatitis, dyslipidemia and metabolic syndrome; cardiovascular disorders
03/2011
03/31/2011WO2011035874A1 N-(1,2,5-oxadiazol-3-yl) benzamides and the use thereof as herbicides
03/31/2011US20110077409 Process for the preparation of certain substituted sulfilimines
03/31/2011US20110077251 Novel 17 beta lupane derivatives
03/31/2011CA2775104A1 N-(1,2,5-oxadiazol-3-yl)benzamides and the use thereof as herbicides
03/30/2011EP2301934A1 Nitrocatechol derivatives as COMT inhibitors
03/30/2011EP2300442A2 Compounds and methods for modulating g protein-coupled receptors
03/29/2011US7915402 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
03/29/2011US7915298 Compounds and methods for leukotriene biosynthesis inhibition
03/24/2011US20110071178 Methods and Compounds for Modulating Cannabinoid Activity
03/24/2011US20110071126 Inhibitors of beta-secretase
03/23/2011EP2297140A1 Novel 1,2,4 oxadiazole compounds and methods of use thereof
03/22/2011US7910613 2-acylaminothiazole derivatives
03/22/2011US7910605 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
03/16/2011EP2295417A1 Novel intermediates useful for preparing alpha-(n-sulfonamido)acetamide compound
03/16/2011EP2205575B1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
03/16/2011EP1417186B1 Heterocyclic aryl sulphonamides
03/16/2011CN101550111B Preparation method of 2,5-bichlorphenyl-1,3,4-furodiazole
03/15/2011US7906724 N-type conjugated materials based on 2-vinyl-4,5-dicyanoimidazoles and their use in organic photovoltaics
03/15/2011US7906652 Heterocycle-substituted 3-alkyl azetidine derivatives
03/10/2011WO2011028651A1 Inhibitors of human 15-lipoxygenase-1
03/10/2011WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof
03/10/2011US20110060019 Heteroaryl-ureas and their use as glucokinase activators
03/09/2011EP2291080A1 Novel modulators of sphingosine phosphate receptors
03/08/2011US7902235 Compounds for nonsense suppression, and methods for their use
03/02/2011EP2289510A1 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
03/02/2011EP2004601B1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
03/02/2011EP1901731B1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
02/2011
02/24/2011US20110046147 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases
02/24/2011US20110042660 Organic luminescent medium and organic el device
02/23/2011EP2285789A1 Novel substituted pyrazoles, 1,2,4-oxadiazoles, and 1,3,4-oxadiazoles
02/17/2011US20110040100 Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
02/17/2011US20110040094 1,3,4-trisubstituted benzenes
02/17/2011US20110039874 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity
02/16/2011EP2284149A1 Selective androgen receptor modulators and methods of use thereof
02/16/2011EP2283001A2 Sulfone compounds which modulate the cb2 receptor
02/16/2011EP1379498B1 Sulphones which modulate the action of gamma secretase
02/15/2011CA2496842C Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/10/2011WO2011016470A1 Sulfone derivative
02/10/2011WO2011016469A1 Amide derivative
02/10/2011US20110034450 Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof
02/10/2011CA2770405A1 Sulfone derivative
02/10/2011CA2770404A1 Amide derivative
02/08/2011US7884103 such as N-(4-Chloro-phenyl)-2-methyl-2-phenylmethanesulfonylamino-3-(4-[1,2,4]triazol-1-yl-phenoxy)-propionamide, used for controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi
02/03/2011US20110028463 Amide compounds
02/03/2011US20110028449 Novel aminomethyl benzene derivatives
02/03/2011US20110024691 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties
02/02/2011EP2280282A1 Methods of detecting Lp-PLA2 activity
02/02/2011EP2279173A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
02/02/2011EP2278879A2 Compounds, compositions and methods comprising oxadiazole derivatives
02/02/2011CN101965339A Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
02/01/2011US7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
02/01/2011US7879995 organic electroluminescent device has, between a pair of electrodes, at least one organic layer including a light-emitting layer, in which the organic layer contains a specific tetraphenylene compound
02/01/2011CA2315717C Inhibition of raf kinase using substituted heterocyclic ureas
01/2011
01/27/2011US20110021448 Inhibitors for the Soluble Epoxide Hydrolase
01/26/2011CN101959881A 5-O-substituted 3-N-phenyl-1,3,4-oxadiazolones for medical use
01/26/2011CN101955470A Potentiators of glutamate receptors
01/25/2011US7875637 Benzimidazole derivative and use as a II receptor antagonist
01/25/2011CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives
01/19/2011EP1581509B1 1-(amino)indanes as edg receptor agonists
01/19/2011CN101952263A Romp-polymerizable electron transport materials based on a bis-oxadiazole moiety
01/18/2011US7872139 Heteroaryl-ureas and their use as glucokinase activators
01/18/2011US7872032 1, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereof
01/18/2011CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
01/13/2011WO2010012442A8 Insecticidal benzenedicarboxamide derivative
01/12/2011CN101945863A Oxadiazole derivatives active on sphingosine-1-phosphate (s1p)
01/12/2011CN101945859A Bis-(sulfonylamino) derivatives in therapy
01/12/2011CN101945848A Tetrasubstituted benzenes
01/11/2011US7868204 Inhibitors of histone deacetylase
01/11/2011US7868031 Propionamide compounds as antiinflammatory agents
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 72